Journal article · 2026 · Open access
Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease
Proceedings of the National Academy of Sciences, 123(7), e2530977123 · Published 9 February 2026 · DOI 10.1073/pnas.2530977123
In brief
“Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease” is a 2026 journal article by Pavle Boskovic and 8 co-authors, published in Proceedings of the National Academy of Sciences. OpenAlex counts 20 citations as of 18 November 2026, which puts it in the top 1% of works published in 2026 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Proceedings of the National Academy of Sciences.
- Citations
- 20
- Most cited in
- 2026 (20)
- Field-weighted impact
- 26.47
- References
- 59
- Authors
- 9
Abstract
Alzheimer’s disease (AD) is the prevailing cause of age-associated dementia worldwide. Current standard of care relies on antibody-based immunotherapy. However, antibody-based approaches carry risks for patients, and their effects on cognition are marginal. Increasing evidence suggests that T cells contribute to AD onset and progression. Unlike the cytotoxic effects of CD8 + cells, CD4 + T cells capable of regulating inflammation show promise in reducing pathology and improving cognitive outcomes in mouse models of AD and in aging. Here, we sought to exploit the beneficial properties of CD4 + T cells while circumventing the need for TCR and peptide–MHC antigen discovery, thereby providing a potential universal therapeutic approach. To achieve this, we engineered CD4 + T cells with chimeric antigen receptors (CARs) targeting fibrillar forms of aggregated amyloid-β. Our findings demonstrate that optimized CAR-T cells can alter amyloid deposition in the dura and reduce parenchymal pathology in the brain. Furthermore, we observed that CAR-T treatment promotes the expansion and recruitment of endogenous CD4 + T cells into the brain parenchyma and leptomeninges. In summary, we established the feasibility of amyloid plaque–specific CAR-T cells as a potential therapeutic avenue for AD. These findings highlight the potential of CD4 + CAR-T therapy not only to modify amyloid pathology but also to reshape the immune landscape of the CNS, paving the way for future development of cellular immunotherapies for neurodegenerative disease.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Boskovic, P., Shalita, R., Gao, W., Vernon, H., Deng, Y. L., Colonna, M., Majzner, R. G., Amit, I., & Kipnis, J. (2026). Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease. Proceedings of the National Academy of Sciences, 123(7), e2530977123. https://doi.org/10.1073/pnas.2530977123
MLA 9
Boskovic, Pavle, et al. “Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease.” Proceedings of the National Academy of Sciences, vol. 123, no. 7, 2026, p. e2530977123. https://doi.org/10.1073/pnas.2530977123.
Chicago
Boskovic, Pavle, Rotem Shalita, Wenqing Gao, Hailey Vernon, Yu Lin Deng, Marco Colonna, Robbie G. Majzner, Ido Amit, and Jonathan Kipnis. 2026. “Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease.” Proceedings of the National Academy of Sciences 123 (7): e2530977123. https://doi.org/10.1073/pnas.2530977123.
Harvard
Boskovic, P. et al. (2026) ‘Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease’, Proceedings of the National Academy of Sciences, 123(7), p. e2530977123. doi:10.1073/pnas.2530977123.
IEEE
P. Boskovic et al., “Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease,” Proceedings of the National Academy of Sciences, vol. 123, no. 7, p. e2530977123, 2026, doi: 10.1073/pnas.2530977123.
BibTeX
@article{boskovic2026engineering,
title = {{Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease}},
author = {Boskovic, Pavle and Shalita, Rotem and Gao, Wenqing and Vernon, Hailey and Deng, Yu Lin and Colonna, Marco and Majzner, Robbie G. and Amit, Ido and Kipnis, Jonathan},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {7},
pages = {e2530977123},
doi = {10.1073/pnas.2530977123},
url = {https://doi.org/10.1073/pnas.2530977123}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Alzheimer's disease
- chimeric antigen receptor T cells
- CD4+ T cells
- amyloid-beta fibrils
- amyloid plaques
- CAR-T immunotherapy
- neuroinflammation
- leptomeninges
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Boskovic, P., Shalita, R., Gao, W., Vernon, H., Deng, Y. L., Colonna, M., Majzner, R. G., Amit, I., & Kipnis, J. (2026). Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease. Proceedings of the National Academy of Sciences, 123(7), e2530977123. https://doi.org/10.1073/pnas.2530977123
How many times has this paper been cited?
20 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Proceedings of the National Academy of Sciences: sign in and open the full text from this page.
Who wrote this paper?
Pavle Boskovic, Rotem Shalita, Wenqing Gao, Hailey Vernon, Yu Lin Deng, Marco Colonna, Robbie G. Majzner, Ido Amit, Jonathan Kipnis.
What is the DOI of this paper?
10.1073/pnas.2530977123, permanently at https://doi.org/10.1073/pnas.2530977123. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.